Showing 1261-1270 of 10608 results for "".
How to Use ChatGPT to Create a Social Media Content Calendar for Your Practice
https://practicaldermatology.com/topics/practice-management/how-to-use-chatgpt-to-create-a-social-media-content-calendar-for-your-practice/23968/ChatGPT can help you ideate content and post it with consistency.Guide to Surviving Consolidation
https://practicaldermatology.com/topics/practice-management/guide-to-surviving-consolidation/20874/A physician coach offers practical advice for dermatologists facing consolidation.Physician Spotlight: J. Matthew Knight, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-j-matthew-knight-md-faad/20561/Dermatologists must act now to extinguish burnout or risk dire consequences.Just Take a Knee and Sit this One Out
https://practicaldermatology.com/topics/practice-management/just-take-a-knee-and-sit-this-one-out/20569/Physician Spotlight: Lynn McKinley-Grant, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-1/22990/Of Mips and Tucks: Making Sense of the Latest Serving of CMS' Alphabet Soup
https://practicaldermatology.com/topics/practice-management/of-mips-and-tucks-making-sense-of-the-latest-serving-of-cms-alphabet-soup/20989/Get your acronyms in order with this handy guide.State Legislation of EHRs: A Sweeping Precedent?
https://practicaldermatology.com/topics/practice-management/state-ehr-legislation-a-new-precedent/21483/A new law in Massachusetts requires all licensed physicians to be using an EHR by 2015.“OK…if you say so”
https://practicaldermatology.com/topics/skin-cancer-photoprotection/okif-you-say-so/20652/The Effect of Cleansers on the Skin Microbiome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/the-effect-of-cleansers-on-the-skin-microbiome/23269/A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.